Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Published online Nov 19, 2026. doi: 10.5498/wjp.122026
Table 5 Cognitive and functional outcomes
| Outcome measure | Treatment group | Control group | P value |
| MoCA score at baseline | 22.5 ± 3.2 | 22.3 ± 3.1 | 0.715 |
| MoCA score at 12 weeks | 25.8 ± 2.1 | 23.4 ± 2.6 | 0.001 |
| mRS 0-2 at 12 weeks (%) | 63.9 | 46.8 | 0.047 |
| Mean mRS at 12 weeks | 2.1 ± 1.0 | 2.6 ± 1.1 | 0.011 |
| Barthel Index at baseline | 65.4 ± 18.2 | 64.8 ± 17.9 | 0.854 |
| Barthel Index at 12 weeks | 82.3 ± 14.6 | 75.4 ± 16.8 | 0.015 |
- Citation: Song HY, Yang Y, Sun XY, Zhang MJ, Wang SG. Serum proprotein convertase subtilisin/kexin type 9 levels correlate with depression severity in post-stroke patients. World J Psychiatry 2026; 16(11): 122026
- URL: https://www.wjgnet.com/2220-3206/full/v16/i11/122026.htm
- DOI: https://dx.doi.org/10.5498/wjp.122026